Can-Fite BioPharma Ltd. (TLV: CANF)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1.900
0.00 (0.00%)
Jan 21, 2025, 5:24 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 56.88 million as of January 22, 2025. Its market cap has increased by 72.00% in one year.
Market Cap
56.88M
Enterprise Value
39.29M
Revenue
2.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.90
Market Cap Chart
Since June 12, 2006, Can-Fite BioPharma's market cap has increased from 16.04M to 56.88M, an increase of 254.66%. That is a compound annual growth rate of 7.03%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 88.56B |
| Danel (Adir Yeoshua) | 2.55B |
| Kamada | 1.47B |
| Bait Bakfar | 1.05B |
| Novolog (Pharm-Up 1966) | 965.26M |
| Ilex Medical | 870.07M |
| BrainsWay | 690.44M |
| SofWave Medical | 608.67M |